Clinical trials recruiting in Alken, Belgium
7
Recruiting trials
12
Conditions
Phase breakdown
Phase 3 7
Conditions recruiting in Alken, Belgium
Recruiting trials in Alken, Belgium
- A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight
- A Study to Evaluate KarXT as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-4)
- EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
- Long-Term Study to Assess the Safety and Tolerability of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
- NBI-1065845-MDD3026: Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
- Open-Label Extension Study to Assess the Long-Term Safety and Tolerability of KarXT in Subjects With Psychosis Associated With Alzheimer's Disease (ADEPT-3)
- Research Study on How Well Oral Semaglutide Works for Weight Loss in Adults With Excess Body Weight
Common questions
How many clinical trials are recruiting in Alken, Belgium?
7 recruiting trials have at least one study site in Alken, Belgium.
Is this list complete?
No. For the full record, search ClinicalTrials.gov.